EBITDA Summary of Formosa Laboratories, Inc.

Formosa Laboratories, Inc.'s latest annual EBITDA in 2023 was 1.16 Billion TWD , up 36.58% from previous year.
Formosa Laboratories, Inc.'s latest quarterly EBITDA in 2024 Q2 was 293.43 Million TWD , up 192.98% from previous quarter.
Formosa Laboratories, Inc. reported an annual EBITDA of 851.76 Million TWD in 2022, down -45.98% from previous year.
Formosa Laboratories, Inc. reported an annual EBITDA of 1.57 Billion TWD in 2021, up 81.18% from previous year.
Formosa Laboratories, Inc. reported a quarterly EBITDA of 293.43 Million TWD for 2024 Q2, up 192.98% from previous quarter.
Formosa Laboratories, Inc. reported a quarterly EBITDA of N/A for 2023 FY, up 36.58% from previous quarter.

Annual EBITDA Chart of Formosa Laboratories, Inc. (2023 - 2009)

Historical Annual EBITDA of Formosa Laboratories, Inc. (2023 - 2009)

Year	EBITDA	EBITDA Growth
2023	1.16 Billion TWD	36.58%
2022	851.76 Million TWD	-45.98%
2021	1.57 Billion TWD	81.18%
2020	870.22 Million TWD	127.69%
2019	372.91 Million TWD	-20.33%
2018	481.64 Million TWD	-22.17%
2017	616.21 Million TWD	-32.24%
2016	928.52 Million TWD	49.6%
2015	556.69 Million TWD	15.28%
2014	467.44 Million TWD	344.22%
2013	119.11 Million TWD	-27.75%
2012	165.68 Million TWD	-57.11%
2011	378.49 Million TWD	-2.82%
2010	395.32 Million TWD	0.0%
2009	- TWD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	116.37 Million TWD	-72.43%
2024 Q2	293.43 Million TWD	192.98%
2023 FY	- TWD	36.58%
2023 Q4	363.27 Million TWD	912.22%
2023 Q3	35.88 Million TWD	-83.38%
2023 Q2	215.96 Million TWD	185.24%
2023 Q1	75.71 Million TWD	-83.67%
2022 Q3	618.9 Million TWD	660.39%
2022 Q1	-312.22 Million TWD	-232.16%
2022 FY	- TWD	-45.98%
2022 Q4	463.69 Million TWD	-25.08%
2022 Q2	81.39 Million TWD	126.07%
2021 Q3	-300.11 Million TWD	-137.27%
2021 Q2	805.27 Million TWD	-30.91%
2021 FY	- TWD	81.18%
2021 Q1	1.16 Billion TWD	26620.52%
2021 Q4	-93.99 Million TWD	68.68%
2020 Q2	625.83 Million TWD	2724.81%
2020 Q3	217.87 Million TWD	-65.19%
2020 FY	- TWD	127.69%
2020 Q1	22.15 Million TWD	2725.0%
2020 Q4	4.36 Million TWD	-98.0%
2019 Q2	-19.95 Million TWD	-118.3%
2019 Q1	109.06 Million TWD	-41.55%
2019 Q4	-844 Thousand TWD	-100.29%
2019 Q3	293.93 Million TWD	1572.98%
2019 FY	- TWD	-20.33%
2018 Q1	216.96 Million TWD	85.44%
2018 Q3	-43.67 Million TWD	-136.45%
2018 Q4	186.59 Million TWD	527.21%
2018 FY	- TWD	-22.17%
2018 Q2	119.82 Million TWD	-44.78%
2017 Q3	129.09 Million TWD	-45.24%
2017 Q2	235.74 Million TWD	75.3%
2017 Q1	134.48 Million TWD	-44.89%
2017 FY	- TWD	-32.24%
2017 Q4	117 Million TWD	-9.37%
2016 Q2	265.67 Million TWD	33.01%
2016 FY	- TWD	49.6%
2016 Q3	200.09 Million TWD	-24.68%
2016 Q1	199.74 Million TWD	-2.45%
2016 Q4	244.02 Million TWD	21.96%
2015 Q4	204.75 Million TWD	-1.01%
2015 Q2	87.22 Million TWD	-20.1%
2015 Q1	109.15 Million TWD	-11.54%
2015 Q3	206.85 Million TWD	137.16%
2015 FY	- TWD	15.28%
2014 Q1	114.57 Million TWD	5.61%
2014 FY	- TWD	344.22%
2014 Q4	123.39 Million TWD	-24.26%
2014 Q3	162.93 Million TWD	28.8%
2014 Q2	126.5 Million TWD	10.41%
2013 Q4	108.49 Million TWD	24.73%
2013 Q1	-127.38 Million TWD	-734.84%
2013 Q2	50.63 Million TWD	139.75%
2013 FY	- TWD	-27.75%
2013 Q3	86.98 Million TWD	71.79%
2012 Q2	62.06 Million TWD	3.43%
2012 Q1	60 Million TWD	-31.45%
2012 Q3	21.21 Million TWD	-65.82%
2012 Q4	20.06 Million TWD	-5.4%
2012 FY	- TWD	-57.11%
2011 Q1	108.43 Million TWD	-72.5%
2011 Q4	87.53 Million TWD	-21.02%
2011 Q2	76.33 Million TWD	-29.6%
2011 Q3	110.83 Million TWD	45.18%
2011 FY	- TWD	-2.82%
2010 Q4	394.24 Million TWD	0.0%
2010 Q1	- TWD	0.0%
2010 Q2	- TWD	0.0%
2010 FY	- TWD	0.0%
2010 Q3	- TWD	0.0%
2009 FY	- TWD	0.0%

Peer EBITDA Comparison of Formosa Laboratories, Inc.

Name	EBITDA	EBITDA Difference
Grape King Bio Ltd	2.88 Billion TWD	59.677%
Standard Chem & Pharm CO., LTD.	1.57 Billion TWD	26.325%
Maywufa Company Ltd.	239.81 Million TWD	-385.086%
ScinoPharm Taiwan, Ltd.	819.15 Million TWD	-42.013%
Lotus Pharmaceutical Co., Ltd.	6.87 Billion TWD	83.069%
LIWANLI Innovation Co., Ltd.	6.81 Million TWD	-16982.291%
YungShin Global Holding Corporation	1.35 Billion TWD	14.297%
PhytoHealth Corporation	-20.69 Million TWD	5720.369%
SCI Pharmtech, Inc.	529.61 Million TWD	-119.652%
PharmaEssentia Corporation	-671.48 Million TWD	273.243%
Bora Pharmaceuticals Co., LTD.	5.73 Billion TWD	79.713%

Global Stocks Search

Formosa Laboratories, Inc. (4746.TW)

EBITDA Summary of Formosa Laboratories, Inc.

Annual EBITDA Chart of Formosa Laboratories, Inc. (2023 - 2009)

Historical Annual EBITDA of Formosa Laboratories, Inc. (2023 - 2009)

Peer EBITDA Comparison of Formosa Laboratories, Inc.